Myriad Genetics (MYGN) Cash from Operations Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -101.15% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 64.87% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 1.77% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 11.89% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 25.34% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 8.80% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -9.63% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 20.42% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -28.11% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | 3.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.68% |
| Dec 31, 2025 | 60.61% |
| Sep 30, 2025 | 2,914.29% |
| Jun 30, 2025 | -623.08% |
| Mar 31, 2025 | 12.37% |
| Dec 31, 2024 | 112.07% |
| Sep 30, 2024 | 103.17% |
| Jun 30, 2024 | 388.89% |
| Mar 31, 2024 | 43.98% |
| Dec 31, 2023 | -649.32% |
| Sep 30, 2023 | -689.29% |
| Jun 30, 2023 | 98.19% |
| Mar 31, 2023 | 28.60% |
| Dec 31, 2022 | 23.16% |
| Sep 30, 2022 | 92.88% |
| Jun 30, 2022 | -1,029.55% |
| Mar 31, 2022 | -164.76% |
| Dec 31, 2021 | 87.11% |
| Sep 30, 2021 | 33.73% |
| Jun 30, 2021 | -109.40% |